510(k) Report

510(k) · Cleared

Cleared

Online Phenobarbital, Model 03016757190 & 03510620

K071644510(k) TraditionalCleared Sep 12, 200789-day reviewClass II21 CFR 862.3660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Roche Diagnostics Corp. · DLZ Enzyme Immunoassay, Phenobarbital

Cleared on Sep 12, 2007 as substantially equivalent to K951595 (Roche Diagnostic Systems, Inc., 1995) after an 89-day review. Its family tree reaches back 1 generation to 1995.

Decided
Sep 12, 2007
Review
89 days
Class
Class II
Product code
DLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K951595 (1995). No later device cites it as a predicate yet.

K951595 · Roche Cobas Integra Analyzer, Reagent Cassettes · Roche Diagnostic Systems, Inc. · 1995 · recalled1996199820002002200420062008
  1. Root · 1 generation backK951595 Roche Cobas Integra Analyzer, Reagent CassettesRoche Diagnostic Systems, Inc. · 1995 · Recalled
  2. This deviceK071644 Online Phenobarbital, Model 03016757190 & 03510620Roche Diagnostics Corp. · 2007
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K951595Roche Cobas Integra Analyzer, Reagent CassettesRoche Diagnostic Systems, Inc.19957
0 (this device)K071644Online Phenobarbital, Model 03016757190 & 03510620Roche Diagnostics Corp.2007—
FIG. 1 — Lineage of K071644, 1995–2007Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DLZ device

  1. #1 K210858 VITROS Chemistry Products PHBR Slidesscore 2.1 · 2 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K951595Roche Cobas Integra Analyzer, Reagent Cassettes
Summary page 1
…ation name: Enzyme Immunoassay, Phenobarbital 3) Predicate We claim substantial equivalence to the currently marketed COBAS device INTEGRA Phenobarbital (K951595). 4) Device The ONLINE TDM Phenobarbital assay is for the quantitative determination Description of phenobarbital i…
Roche Diagnostic Systems, Inc.19957

Also cleared against K951595: 31 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 31 other devices also cite its predicate K951595.

How does its category compare?

All DLZ devices

DLZ Enzyme Immunoassay, Phenobarbital: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · DLZ

1in 2021

2007: 12008: 12013: 12021: 1
2007high 1 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DLZ

Too few DLZ 510(k)s in any year since 2007 to give a median.

Recalls per year · DLZ

2in 2013

2009: 12011: 12012: 22013: 2
2007high 2 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DLZ

1in 2024

2007: 32011: 582012: 2222013: 1012023: 72024: 1
2007high 222 (2012) · low 0 (2008)2025

MAUDE reports naming product code DLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—03
20081—00
20090—10
20100—00
20110—158
20120—2222
20131—2101
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20211—00
20220—00
20230—07
20240—01
20250—00
20260—0—

What is it indicated for?

The ONLINE TDM Phenobarbital assay is for the quantitative determination of phenobarbital in human serum or plasma on Roche automated clinical chemistry analyzers. Measurements obtained by this device are used in the diagnosis and treatment of phenobarbital use or overdose and in monitoring levels of phenobarbital.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071644: Online Phenobarbital, Model 03016757190 & 03510620.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071644

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026